AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard - Yinchengao Decoction plus Ganlu Detoxification Pill
Description: Yinchengao Decoction plus Ganlu Detoxification Pill is one Chinese Medicine Formula for the TCM syndrome: Damp-heat blocking middle jiao.
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Entecavir or Tenofovir
Description: Western drug for anti-HBV such as Entecavir and Tenofovir
Study NCT02384785 — intervention group
Intervention type: DEVICE
Intervention: Transcutaneous Electric Nerve Stimulation
Description: Electric currents: 'Transcutaneous Electric Nerve Stimulation' and Transcranial Direct Current Stimulation will be applied on the back of the patients in parallel to the implanted electrodes. Implanted electrode will measure voltages that generated near the spinal cord tissue.
Study NCT04064944 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: blood purification equipment
Description: The subjects enrolled in this study will undergo blood purification treatment, and will be randomized into either immunoadsorption group or plasma exchange group, and the following indicators will be evaluated: (1) changes in EDSS scores and visual acuity before and after treatment; (2) changes in AQP4-IgG levels; (3) the safety of immunoadsorption treatment.
Study NCT04629365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: KD group consumed less than 50g/day of carbohydrates
Study NCT04629365 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Normal Diet
Description: ND group consumed 55% of the caloric intake from carbohydrates
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir or Tenofovir
Description: Western drug for anti-HBV such as Entecavir and Tenofovir
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard - Ge Xia Zhu Yu Decoction
Description: Ge Xia Zhu Yu Decoction is one Chinese Medicine Formula for the TCM syndrome: internal blood stasis.
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Advanced - Supplemented Taohong Huazhuo Decoction
Description: Supplemented Taohong Huazhuo Decoction is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Damp-heat blocking middle jiao.
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard - Chaihu Shugan San
Description: Chaihu Shugan San is one Chinese Medicine Formula for the TCM syndrome: Liver depression and qi stagnation.
Study NCT01679340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: S-1
Description: Mode of administration: orally (capsules) Dosing schedule:80mg/m2, Bid,D1-14,every 3 week,for 8-10cycles
Study NCT01679340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-1
Description: Mode of administration: orally (capsules) Dosing schedule:80mg/m2, Bid,D1-14,every 3 week,for 8-10cycles
Study NCT01679340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxaliplatin
Description: Mode of administration: intravenously Doseing schedule: 65 mg/m2 D1,D8,every 3 week, for 6 cycles
Study NCT01679340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cisplatin
Description: Mode of administration: intravenously Dosing schedule: 75mg/m2 D1,every 3 week,for 6 cycle
Study NCT02021149 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High intensity whole-body infrared heating
Description: The Whole Body Hyperthermia system uses water-filtered infrared-A (wIRA) heat radiation. The rise in the body's core temperature is correspondingly rapid and well-tolerated. There are two phases of the thermal challenge, 1) Irradiation phase during which the patient lies recumbent with his/her head positioned outside the tent. The wIRA irradiators are arranged above the exposed upper part of the body; and 2) Heat retention phase during which the patient lies in the chamber with the walls of the tent positioned to retain heat. Core body temperatures will be raised to those comparable to a mild fever 37.8-38.5°C.
Study NCT02021149 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Weekly psychotherapy using cognitive behavioral therapy sessions with a therapist.
Study NCT02021149 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Psychotherapy
Description: Weekly psychotherapy using cognitive behavioral therapy sessions with a therapist.
Study NCT02021149 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Psychotherapy
Description: Weekly psychotherapy using cognitive behavioral therapy sessions with a therapist.
Study NCT02021149 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Weekly questionnaires to assess changes in mood, perceptions of self and perceptions of effectiveness of the therapist/patient bond will be administered.
Study NCT02021149 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Questionnaires
Description: Weekly questionnaires to assess changes in mood, perceptions of self and perceptions of effectiveness of the therapist/patient bond will be administered.
Study NCT02021149 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaires
Description: Weekly questionnaires to assess changes in mood, perceptions of self and perceptions of effectiveness of the therapist/patient bond will be administered.
Study NCT02021149 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Low intensity whole-body infrared heating
Description: Attenuated heating using only heating coils at the bottom of the Heckel device. This results in only a minor increase in skin temperature and no increase in core body temperature. The participant will still feel heat and will see similar lighting and hear similar sounds as those occurring during actual WBH, and will be in the chamber for the same period of time.
Study NCT00588380 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLP-1
Description: GLP-1 infused at 0.75 pmol/kg/min from 121-180 minutes, GLP-1 infused at 1.55 pmol/kg/min from 181-240 minutes,
Study NCT03748420 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adherence Intervention
Description: The adherence enhanced intervention consists of clinical decision support related to cardiovascular risk factors enhanced with external medication adherence information and is delivered at the point of care to the healthcare provider and patient.
Study NCT01066650 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endeavor Resolute (Biolinx-based Zotarolimus-eluting stent)
Description: Drug eluting Stent
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Advanced - Soothe the liver and regulate qi Decoction
Description: Soothe the liver and regulate qi Decoction is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Liver depression and qi stagnation.
Study NCT01066650 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Xience V (Everolimus-eluting stent)
Description: Drug eluting stent
Study NCT00862524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARRY-334543, EGFR/ErbB2 inhibitor; oral
Description: multiple dose, escalating
Study NCT00862524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine, nucleoside analogue; intravenous
Description: multiple dose, single schedule
Study NCT04422197 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Botox
Description: effect of botox injection in abdominal wall muscle post major abdominal surgery in terms of postoperative pain, incidence of incisional hernia.
Study NCT04422197 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: surgery without botox injection
Description: surgery without botox injection
Study NCT03045640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FSI ECD
Description: The FSI ECD intervention was delivered in a structured curriculum format, covering a range of topics from health, water and sanitation, good hygiene, early stimulation, conflict resolution, to good communication. It was designed to improve vulnerable households home environment and engagement with their children in order to improve child development outcomes. The curriculum was delivered by bachelor-level trained staff with beneficiaries on an individual, one on one basis, using active coaching to promote child well being and behaviors with caregivers.
Study NCT00438490 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Recombinant Human Prolactin
Study NCT00438490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human Prolactin
Study NCT03516110 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Subjects will be treated in accordance with usual medical practice during their participation in this study. No additional assessments or tests will be required.
Study NCT02132858 — intervention group
Intervention type: OTHER
Intervention: cytology specimen collection procedure
Description: Correlative studies
Study NCT02132858 — intervention group
Intervention type: OTHER
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT03679182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine
Description: Olanzapine 5 mg Tab at 0, 12, 24, and 36 hours
Study NCT01206101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: liraglutide
Description: Dose escalation of liraglutide up to 1.2 to 1.8 mg before islet cell transplant until the planned number of transplanted subjects is complete or subject is transplanted. After islet cell transplant, subjects continue to receive the reached liraglutide dose for 52 weeks. Injected subcutaneously(under the skin) once daily.
Study NCT01206101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Description: Dose escalation escalation of liraglutide up to 1.2 to 1.8 mg before islet cell transplant until the planned number of transplanted subjects is complete or subject is transplanted. After islet cell transplant, subjects continue to receive the reached liraglutide placebo dose for 52 weeks. Injected subcutaneously (under the skin) once daily.
Study NCT01206101 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Dose escalation escalation of liraglutide up to 1.2 to 1.8 mg before islet cell transplant until the planned number of transplanted subjects is complete or subject is transplanted. After islet cell transplant, subjects continue to receive the reached liraglutide placebo dose for 52 weeks. Injected subcutaneously (under the skin) once daily.
Study NCT03645811 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Music therapy was applied in the application room. Via a portable computer, students listened to the mahur maqam for 20 minutes under the supervision of the investigators using an MP3 player.
Study NCT03645811 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EFT
Description: EFT includes taps, nine gamut sequences, and eye movements on the meridian system, focusing on the individual's inhibiting thoughts, disturbing emotions, or memories. EFT regulates the flow of energy in the meridian system of the individual, causing relaxation in the mind, body, and emotions.
Study NCT02868151 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ascorbic Acid
Description: Ascorbic acid oral supplementation 1g four times daily for the entire treatment period and 30 days after treatment by tapering the dose of the drug to half. The drug has to be started 2 days prior to initiation of treatment of cancer.
Study NCT02868151 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc acetate
Description: Zinc acetate 50mg tablets orally twice daily for entire period of cancer treatment
Study NCT03685929 — intervention group
Intervention type: PROCEDURE
Intervention: Punch skin biopsy
Description: Two punch biopsies will be performed in each patient, one at the border of the skin lesion, and one at the adjacent healthy skin. A disposable biopsy punch of 4 mm will be used. A biopsy punch is a small circular blade (like an apple corer) which is rotated into the skin to obtain a cylindrical specimen. Local anaesthesia will be applied and the circular wound will be closed by a single suture. Sutures will be removed after one week.
Study NCT01718366 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deferasirox, Vitamin D and Azacitidine
Description: association of Deferasirox (group 1: 5-10-15/mg/kg/day according to dose level group), Vitamine D (100000U/week) and Azacitidine (75 mg/kg/day day1-day7)
Study NCT01739348 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verubecestat (Part I and Part II)
Description: Single 12 mg verubecestat tablet once daily, taken orally
Study NCT01739348 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verubecestat (Part I and Part II)
Description: Single 40 mg verubecestat tablet once daily, taken orally
Study NCT01739348 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verubecestat (Part I and Part II)
Description: Single 60 or 40 mg verubecestat tablet once daily, taken orally
Study NCT01739348 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Part I)
Description: Single placebo tablet matching verubecestat treatment once daily, taken orally
Study NCT01739348 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Verubecestat (Part II)
Description: Single 40 mg verubecestat tablet once daily, taken orally
Study NCT02632461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Podcasts
Description: Participants will receive twice weekly podcasts that will cover topics related to weight loss.
Study NCT02632461 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Podcasts
Description: Participants will receive twice weekly podcasts that will cover topics related to weight loss.
Study NCT02632461 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mobile Diet Application
Description: Participants will use a mobile application on their smartphone to track their diet.
Study NCT02632461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bite Counter
Description: Participants will use a wrist-worn Bite Counter to track the number of bites in their diet per day.
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard - Xiaoyao powder
Description: Xiaoyao powder is one Chinese Medicine Formula for the TCM syndrome: Stagnation of liver qi and spleen deficiency.
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Advanced - Supplemented Ganbi Decoction
Description: Supplemented Ganbi Decoction is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Stagnation of liver qi and spleen deficiency.
Study NCT00039091 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ipilimumab
Description: Given IV
Study NCT02039128 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Krill oil or Fish oil
Study NCT02039128 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Krill oil or Fish oil
Study NCT02039128 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03510728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: college drinker's check up
Description: The College Drinker's Check-up (CDCU) is a single session, computer-based brief motivational intervention for heavy drinking college students. It takes a student about 45 minutes to go through it.
Study NCT03908879 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard intraosseous (IO) catheter confirmation procedure
Description: The physician will evaluate the ability or inability of the intraosseous (IO) catheter to stand upright unassisted, the ability or inability to aspirate blood or bone marrow from the IO catheter, and whether or not there is visible or palpable extravasation of infusate from the IO catheter insertion site or surrounding subcutaneous tissue during IO catheter use.
Study NCT03908879 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Color flow Doppler intraosseous (IO) catheter confirmation procedure
Description: The high frequency probe of a portable ultrasound with color flow Doppler is placed adjacent to the intraosseous (IO) catheter, visualizing the IO space in long or short axis. Color flow Doppler signal will be turned on during IO use and the physician will determine if the Doppler signal is in the intraosseous space or the extraosseous space. Saved data of the ultrasound image will be reviewed independently by at least two blinded reviewers. If the conclusions from the blinded reviewers are discordant then a third blinded reviewer will evaluate the saved data.
Study NCT03908879 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pressure transduction intraosseous (IO) catheter confirmation procedure
Description: The intraosseous (IO) catheter will be attached to a pressure transducer to demonstrate a waveform on the telemetry monitor. Physicians will evaluate for the presence of a pulsatile waveform with objective measurements of a systolic pressure, diastolic pressure and mean pressure. Saved data of the waveform image will be reviewed independently by at least two blinded reviewers. If the conclusions from the blinded reviewers are discordant then a third blinded reviewer will evaluate the saved data.
Study NCT01475097 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iodixanol
Description: Iodixanol 320 mg I/mL given by intra-arterial administration. Comparator agent Isovue (iopamidol) 370 mg I/mL given as intra-arterial administration.
Study NCT01475097 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iopamidol
Description: Iodixanol 320 mg I/mL given by intra-arterial administration. Comparator agent Isovue (iopamidol) 370 mg I/mL given as intra-arterial administration.
Study NCT02529891 — intervention group
Intervention type: OTHER
Intervention: Measurement of VOC in exhaled air
Description: Measurement of VOC in exhaled air during 10 min (tidal breathing) with a portable mass spectrometer
Study NCT02875964 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroencephalogram
Description: Implanting electrode to measure brain activity
Study NCT02875964 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: magnetoencephalogram
Description: Implanting electrode to measure brain activity
Study NCT03510728 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: college drinker's check up
Description: The College Drinker's Check-up (CDCU) is a single session, computer-based brief motivational intervention for heavy drinking college students. It takes a student about 45 minutes to go through it.
Study NCT03510728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Protective Behavioral Strategies Intervention
Description: This intervention component focuses on educating and promoting PBS activities in future college drinking situations
Study NCT03510728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ecological Momentary Intervention
Description: This EMI is delivered during drinking situations and focuses on promoting PBS use during that particular drinking situation.
Study NCT02966899 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Study NCT00926263 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CP-751,871
Description: single dose, 1-hr IV infusion
Study NCT00926263 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CP-751,871, moxifloxacin, saline
Description: Two doses at 20 mg/kg each on two consecutive days, each administered via 1-hr IV infusion
Study NCT01492738 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture
Description: After completing questionnaires and anxiety survey, a licensed acupuncturist will insert needles according to Clean Needle Technique into specific acupuncture points. Procedure will last 20 minutes.Following acupuncture treatment, participants will complete anxiety survey and memory test.
Study NCT02315833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetium
Description: Capsule for oral administration contains L-cysteine 100mg
Study NCT03628625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5mg
Description: total dose 7.5 mg per day for 3 days
Study NCT03628625 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Folic acid for 3 days
Study NCT03628625 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Misoprostol
Description: Misoprosrol 800mcg will be given to all patients for induction of abortion
Study NCT03628625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol
Description: Misoprosrol 800mcg will be given to all patients for induction of abortion
Study NCT01581866 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ziprasidone Hydrochloride
Description: Ziprasidone HCL Capsules, 20 mg
Study NCT04181073 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Jet Nebuliser
Description: Jet Nebuliser
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard - Yiguan Decoction
Description: Yiguan Decoction is one Chinese Medicine Formula for the TCM syndrome: Yin deficiency of liver and kidney.
Study NCT03018821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Advanced - Supplemented Zimu Dan
Description: Supplemented Zimu Dan is one Chinese Medicine Formula suggested by national wide known TCM doctors who expertise in chronic hepatitis B for the TCM syndrome: Yin deficiency of liver and kidney.